Shares of Vitalhub Corp. (TSE:VHI – Get Free Report) traded down 18.9% during trading on Friday. The company traded as low as C$6.49 and last traded at C$6.49. 870,732 shares were traded during trading, an increase of 195% from the average session volume of 294,716 shares. The stock had previously closed at C$8.00.
Analyst Ratings Changes
Separately, Canaccord Genuity Group set a C$15.00 price target on shares of Vitalhub and gave the company a “buy” rating in a research report on Friday, August 28th. Six research analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of C$12.67.
View Our Latest Stock Analysis on Vitalhub
Vitalhub Price Performance
The firm has a market capitalization of C$441.47 million, a P/E ratio of 58.08, a P/E/G ratio of 1.18 and a beta of 1.37. The stock has a fifty day simple moving average of C$7.58 and a two-hundred day simple moving average of C$7.59.
Vitalhub (TSE:VHI – Get Free Report) last posted its quarterly earnings results on Thursday, November 12th. The company reported C$0.04 EPS for the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%. The business had revenue of C$31.91 million during the quarter. As a group, sell-side analysts expect that Vitalhub Corp. will post 0.23 EPS for the current fiscal year.
About Vitalhub
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Further Reading
- Five stocks we like better than Vitalhub
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
